Mission
To be the healthcare sector’s leading technology partner for traceability and safety solutions
Our foundation
Specialisation
“We provide automation and security solutions.”
- We are experts in the automatic control of production and care processes in the healthcare sector.
Our realm are processes with biological and pharmacological products for medical use.
- Our solutions are designed and tailored to users desires.
Innovation
“We combine cutting-edge technology and innovation.”
- We design sustainable solutions that are based on cutting-edge technology already used in other sectors.
- We us a self-developed platform for hard and software which we tailor on clients’ desires.
Human team
“We listen to customers desires and colaborate effectively”
- We are a team of engineers who have the goal to help medical professionals in their daily working life.
We cooperate closely with our customer base to ensure everything is always fine tuned
Our team
Our team is formed by a group of professionals, of recognised talent with experience and the proven ability to develop innovative technological solutions.
Our history
2009. Foundation of AT-Biotech with the support of the CAMPUS program and promoted by the Agency for Innovation and Development of Andalusia (IDEA).
2013 – March. Casiopea ESm2m, a company pertaining to the firm Ámbar Venture Capital , acquires 100% of AT-Biotech to develop traceability solutions for the health sector. The development of Rhesus begins.
2013 – December. Signing of a collaboration agreement with the Biobanco de Andalucía for the live testing, proof of concept and implementation of Rhesus at the Blood Transfusion Centre of Seville-Huelva.
2014 – August. El Banc de Sang i Teixits de Catalunya (BST) (The Blood bank of Catalunya) approves a pilot project of Rhesus at the Dr. Josep Trueta Hospital (Girona) to improve blood transfusion safety.
2015 – January. AT-Biotech starts testing the system with Banc de Sang i Teixits de Catalunya (BST). The goal of transfusing 100 patients without errors is successfully exceeded.
2015 – June. Two first international publications -congress of the International Society of Blood Transfusion (ISBT), London-. Award for the best communication -congress of the Spanish Society of Blood Transfusion and Cell Therapy (SETS) Seville-.
2015 – December. Milestone successfully achieved im Seville: 200.000 blood components controlled by Rhesus.
2016 – March. First contract with BST to implement Rhesus in the main hospitals of Catalonia..
2017 – May. Launch of our Frigea Blood solution for the cold chain control of blood components.
2018 – June. El Banco de Sangre y Tejidos de Cantabria (The Blood and Tissue Bank of Cantabria) adopts Frigea blood to control the cold chain of blood shipments between the headquarters and the hospitals of the Autonomous Community.
2018 – December. The Fundació del Banc de Sang i Teixits de Baleares (FSTIB) (The blood and tissues’ foundation of Balearic Islands) adopts Rhesus to manage the donation and processing of blood components.
2019 – October. La Fundació del Banc de Sang i Teixits de Baleares (FSTIB) (The blood and tissues foundation of Balearic Islands adopts Rhesus to manage the handling and storage of human tissues for donations.
2020 – November. El Centro Vasco de Transfusión y Tejidos Humanos (CVTTH) (The Centre for Transfusion and Human Tissues of Basque country) adopts Frigea Blood as a solution to control the cold chain of shipments of blood, tissue and breast milk between the 48 points of the network.
2021 – June. AT-Biotech begins to test a fully automatic logistic control system for the cold-storage warehouses of the multinational corporation Grifols.
2021 – November. AT-Biotech to launch the new version of Rhesus featuring blended RFID and Barcode Data matrix capabilities.
Our foundation
Specialisation
“We provide automation and security solutions.”
- We are experts in the automatic control of production and care processes in the healthcare sector.
Our realm are processes with biological and pharmacological products for medical use.
- Our solutions are designed and tailored to users desires.
Innovation
“We combine cutting-edge technology and innovation.”
- We design sustainable solutions that are based on cutting-edge technology already used in other sectors.
- We us a self-developed platform for hard and software which we tailor on clients’ desires.
Human team
“We listen to customers desires and colaborate effectively”
- We are a team of engineers who have the goal to help medical professionals in their daily working life.
We cooperate closely with our customer base to ensure everything is always fine tuned
Our team
Our team is formed by a group of professionals, of recognised talent with experience and the proven ability to develop innovative technological solutions.
Our history
2009. Foundation of AT-Biotech with the support of the CAMPUS program and promoted by the Agency for Innovation and Development of Andalusia (IDEA).
2013 – March. Casiopea ESm2m, a company pertaining to the firm Ámbar Venture Capital , acquires 100% of AT-Biotech to develop traceability solutions for the health sector. The development of Rhesus begins.
2013 – December. Signing of a collaboration agreement with the Biobanco de Andalucía for the live testing, proof of concept and implementation of Rhesus at the Blood Transfusion Centre of Seville-Huelva.
2014 – August. El Banc de Sang i Teixits de Catalunya (BST) (The Blood bank of Catalunya) approves a pilot project of Rhesus at the Dr. Josep Trueta Hospital (Girona) to improve blood transfusion safety.
2015 – January. AT-Biotech starts testing the system with Banc de Sang i Teixits de Catalunya (BST). The goal of transfusing 100 patients without errors is successfully exceeded.
2015 – June. Two first international publications -congress of the International Society of Blood Transfusion (ISBT), London-. Award for the best communication -congress of the Spanish Society of Blood Transfusion and Cell Therapy (SETS) Seville-.
2015 – December. Milestone successfully achieved im Seville: 200.000 blood components controlled by Rhesus.
2016 – March. First contract with BST to implement Rhesus in the main hospitals of Catalonia..
2017 – May. Launch of our Frigea Blood solution for the cold chain control of blood components.
2018 – June. El Banco de Sangre y Tejidos de Cantabria (The Blood and Tissue Bank of Cantabria) adopts Frigea blood to control the cold chain of blood shipments between the headquarters and the hospitals of the Autonomous Community.
2018 – December. The Fundació del Banc de Sang i Teixits de Baleares (FSTIB) (The blood and tissues’ foundation of Balearic Islands) adopts Rhesus to manage the donation and processing of blood components.
2019 – October. La Fundació del Banc de Sang i Teixits de Baleares (FSTIB) (The blood and tissues foundation of Balearic Islands adopts Rhesus to manage the handling and storage of human tissues for donations.
2020 – November. El Centro Vasco de Transfusión y Tejidos Humanos (CVTTH) (The Centre for Transfusion and Human Tissues of Basque country) adopts Frigea Blood as a solution to control the cold chain of shipments of blood, tissue and breast milk between the 48 points of the network.
2021 – June. AT-Biotech begins to test a fully automatic logistic control system for the cold-storage warehouses of the multinational corporation Grifols.
2021 – November. AT-Biotech to launch the new version of Rhesus featuring blended RFID and Barcode Data matrix capabilities.
our Clients
our Clients
Accreditations
Horizon 2020, the financial instrument implemented by the Business Innovation Union, is an initiative aimed to ensure Europe’s global competitiveness.
Horizon 2020, is considered to be a means of boosting economic growth and job creation in the region, has the political support of European leaders and members of the European Parliament.
Certificate of PYME Innovadora, or Innovative SME by the Spanish Ministery of Science and Innovation. Program and official stamps regulated by legal decrees Real Decreto 475/2014 and Orden ECC/1087/2015
The Spanish Society of Blood Transfusion is the scientific association of professionals dedicated to the donation and transfusion of blood.
Its objectives are the promotion of the investigation, discussion, dissemination and application of scientific advances related to blood banks among its associated members. In addition, other areas such as biotechnology and the technical development of organ and tissue transplants are also in scope.
ISO 2859-1. Sampling procedures for attribute inspection – Part 1. Sampling schemes indexed by NCA (Acceptable Quality Level or AQL) for batch-by-batch inspection.
The International Blood Transfusion Society (ISBT) is a scientific society that was founded in 1935.
Since then, ISBT has become an international society where transfusion medicine professionals from around the world come together and do what they do best: share knowledge to improve the safety of blood transfusions around the globe.
Patents
AT-Biotech has developed innovative technologies that are applied in its cold chain traceability and control solutions. This technology is protected by the following patents:
- PCT/EP2020/058424 – Method, system and device for monitoring and labelling biological and pharmaceutical products
- PCT/EP2020/055061 – Method and system for monitoring and preventing errors in the use of biological and pharmaceutical products
Accreditations
Horizon 2020, the financial instrument implemented by the Business Innovation Union, is an initiative aimed to ensure Europe’s global competitiveness.
Horizon 2020, is considered to be a means of boosting economic growth and job creation in the region, has the political support of European leaders and members of the European Parliament.
Certificate of PYME Innovadora, or Innovative SME by the Spanish Ministery of Science and Innovation. Program and official stamps regulated by legal decrees Real Decreto 475/2014 and Orden ECC/1087/2015
The Spanish Society of Blood Transfusion is the scientific association of professionals dedicated to the donation and transfusion of blood.
Its objectives are the promotion of the investigation, discussion, dissemination and application of scientific advances related to blood banks among its associated members. In addition, other areas such as biotechnology and the technical development of organ and tissue transplants are also in scope.
ISO 2859-1. Sampling procedures for attribute inspection – Part 1. Sampling schemes indexed by NCA (Acceptable Quality Level or AQL) for batch-by-batch inspection.
The International Blood Transfusion Society (ISBT) is a scientific society that was founded in 1935.
Since then, ISBT has become an international society where transfusion medicine professionals from around the world come together and do what they do best: share knowledge to improve the safety of blood transfusions around the globe.
Patents
AT-Biotech has developed innovative technologies that are applied in its cold chain traceability and control solutions. This technology is protected by the following patents:
- PCT/EP2020/058424 – Method, system and device for monitoring and labelling biological and pharmaceutical products
- PCT/EP2020/055061 – Method and system for monitoring and preventing errors in the use of biological and pharmaceutical products
Where to find us
Madrid
C/ Reyes Magos, 18 – Bajo Derecha
28009 Madrid España
Where to find us
Madrid
C/ Reyes Magos, 18 – Bajo Derecha
28009 Madrid España